Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych TopicsConsultation-liaison psychiatry

Psych · Consultation-liaison psychiatry

Wilson disease and metabolic neuropsychiatry

Also known as Wilson's disease psychiatry · Hepatolenticular degeneration psychiatry · ATP7B copper neuropsychiatry · Wilson disease psychosis · Wilson disease depression · Metabolic neuropsychiatry Wilson · Chelation penicillamine psychiatry · Kayser-Fleischer psychiatric presentation

Exam-exhaustive fellowship topic on Wilson disease and metabolic neuropsychiatry: ATP7B copper toxicity, personality change and irritability, depression, psychosis, cognition, Leipzig score diagnostics, lifelong chelation and zinc, paradoxical neurologic worsening, psychotropic choice with basal ganglia and liver disease, family screening, transplant interface, and treatable metabolic differentials. FRANZCP-primary, globally tagged.

medium14 referencesUpdated 26 July 202613 min readVerification in progress

Practise this topic

  • 10 MCQs

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Young adult with new psychosis or personality change plus tremor, dystonia, dysarthria, or unexplained LFT abnormality — screen for Wilson disease before locking a primary schizophrenia label
  • Non-adherence to lifelong anticopper therapy risks hepatic failure and irreversible neurologic injury
  • Paradoxical neurologic (and sometimes psychiatric) worsening after starting D-penicillamine too aggressively
  • High-potency typical antipsychotics can devastate movement in basal-ganglia copper disease
  • Acute liver failure, Coombs-negative haemolysis, or encephalopathy — medical emergency, not pure psychiatry
  • Suicide risk in severe depression or after functional decline — assess every contact
  • Asymptomatic siblings of index cases need cascade screening
On this page
Study tools

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Young adult with new psychosis or personality change plus tremor, dystonia, dysarthria, or unexplained LFT abnormality — screen for Wilson disease before locking a primary schizophrenia label
  • Non-adherence to lifelong anticopper therapy risks hepatic failure and irreversible neurologic injury
  • Paradoxical neurologic (and sometimes psychiatric) worsening after starting D-penicillamine too aggressively
  • High-potency typical antipsychotics can devastate movement in basal-ganglia copper disease
  • Acute liver failure, Coombs-negative haemolysis, or encephalopathy — medical emergency, not pure psychiatry
  • Suicide risk in severe depression or after functional decline — assess every contact
  • Asymptomatic siblings of index cases need cascade screening
The one-line answer

Wilson disease is a treatable autosomal-recessive ATP7B copper disorder that walks onto a psychiatry ward years before anyone thinks of the liver. The face is personality change, irritability, depression, psychosis and executive decline; the trigger to think copper is any young patient with movement signs or unexplained liver tests. Diagnose with ceruloplasmin, 24-hour urine copper, slit-lamp Kayser–Fleischer rings, the Leipzig score and ATP7B genetics, start lifelong anticopper therapy low-and-slow, and treat psychiatric targets with hepatic- and EPS-aware psychotropics — never high-potency typicals into a copper-laden basal ganglia.[1][2][7][10]

Meet the patient

A 19-year-old man is referred from the first-episode psychosis service. Eighteen months ago he was a calm, high-achieving engineering student. Then the fights began — verbal, then physical, then a suspension. Six months ago he grew convinced his lecturers were poisoning him.[3][4]

Three months ago a tremor appeared in his writing hand. His liver enzymes came back abnormal. Nobody joined the dots. The psychosis team plan to start a depot antipsychotic this afternoon.[1][4]

Two questions decide his next decade. Why is a bright young man now tremulous and paranoid? And why are his liver enzymes abnormal? Miss the join and he gets a lifelong schizophrenia label, a movement-devastating depot, and a liver that fails in his thirties. Catch it and copper chelation can give him his life back.[1][2][12]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References14ShowHide
  1. [1]Zimbrean PC, Schilsky ML Psychiatric aspects of Wilson disease: a review Gen Hosp Psychiatry, 2014.PMID 24120023
  2. [2]Litwin T, Dusek P, Szafrański T, et al. Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment Ther Adv Psychopharmacol, 2018.PMID 29977520
  3. [3]Dening TR, Berrios GE Wilson's disease. Psychiatric symptoms in 195 cases Arch Gen Psychiatry, 1989.PMID 2589927
  4. [4]Akil M, Schwartz JA, Dutchak D, et al. The psychiatric presentations of Wilson's disease J Neuropsychiatry Clin Neurosci, 1991.PMID 1821256
  5. [5]Akil M, Brewer GJ Psychiatric and behavioral abnormalities in Wilson's disease Adv Neurol, 1995.PMID 7872138
  6. [6]Mura G, Zimbrean PC, Demelia L, Carta MG Psychiatric comorbidity in Wilson's disease Int Rev Psychiatry, 2017.PMID 28681670
  7. [7]Schilsky ML, Roberts EA, Bronstein JM, et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases Hepatology, 2025.PMID 36151586
  8. [8]European Association for Study of Liver EASL Clinical Practice Guidelines: Wilson's disease J Hepatol, 2012.PMID 22340672
  9. [9]European Association for the Study of the Liver EASL-ERN Clinical Practice Guidelines on Wilson's disease J Hepatol, 2025.PMID 40089450
  10. [10]Członkowska A, Litwin T, Dusek P, et al. Wilson disease Nat Rev Dis Primers, 2018.PMID 30190489
  11. [11]Weiss KH, Thurik F, Gotthardt DN, et al. Efficacy and safety of oral chelators in treatment of patients with Wilson disease Clin Gastroenterol Hepatol, 2013.PMID 23542331
  12. [12]Ferenci P Diagnosis of Wilson disease Handb Clin Neurol, 2017.PMID 28433100
  13. [13]Dening TR, Berrios GE Wilson's disease: a longitudinal study of psychiatric symptoms Biol Psychiatry, 1990.PMID 2378928
  14. [14]Merle U, Schaefer M, Ferenci P, Stremmel W Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study Gut, 2007.PMID 16709660

Test yourself

Practise what you just read

  • 10 MCQs
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousTraumatic brain injury psychiatryConsultation-liaison psychiatryNextAbsconding and missing patientsEmergency psychiatry — absconding and missing patients